This week we highlighted findings from recently published cost-effectiveness studies:
- Exercise program during cancer treatment cost-effective for colon cancer, but not breast cancer patients: An exercise intervention begun early after diagnosis was found to be more beneficial and less costly for colon cancer patients than for breast cancer patients in the Netherlands. (3)
- Review of influenza immunization programs evaluate cost-effectiveness of universal versus targeted approaches: A universal approach over a targeted approach was found to be more cost-effective with an emphasis on vaccinating high-risk individuals. (6)
- Different non-pharmacological treatments reviewed for knee osteoarthritis: A review of 11 non-pharmacological treatments for knee osteoarthritis in the UK found transcutaneous electrical nerve Stimulation (TENS) to be the most cost-effective. Among only higher quality RCTs reviewed, acupuncture was cost-effective. (9)
See below for a full list of all cost-utility studies and selected reviews and editorials published March 6-10, 2017. To discover more CEA articles or to dive in-depth on some of these topics, please visit the Tufts CEA Registry. Follow us on Twitter (@TuftsCEVR) and Facebook.
1: Buti M, Domínguez-Hernández R, Oyagüez I, Casado MA, Esteban R. Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis. J Viral Hepat. 2017 Mar 8. PMID: 28273410.
2: Hunt B, Mocarski M, Valentine WJ, Langer J. Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA. Adv Ther. 2017 Mar 9. PMID: 28281218.
3: May AM, et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017 Mar 6;7(3):e012187. PMID: 28264824.
4: Moriwaki K, Mouri M, Hagino H. Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan. Osteoporos Int. 2017 Mar 6. PMID: 28265718.
5: Schmier JK, Ong KL, Fonarow GC. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System. Clin Cardiol. 2017 Mar 8.PMID: 28272808.
6: Ting EE, Sander B, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs. Vaccine. 2017 Mar 8. PMID:28284681.
7: Wilson MR, Bergman A, Chevrou-Severac H, Selby R, Smyth M, Kerrigan MC. Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. Eur J Health Econ. 2017 Mar 8. PMID: 28271250.
8: Wirth D, Dass R, Hettle R. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany. BMC Health Serv Res. 2017 Mar 8;17(1):182. PMID: 28270207.
9: Woods B, et al. Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. PLoS One. 2017 Mar 7;12(3):e0172749. PMID: 28267751.
10: Xu X, Yonkers KA, Ruger JP. Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial. BMC Pregnancy Childbirth. 2017 Mar 7;17(1):83. PMID: 28270105.